Grand Opening Celebrates Expansion of Patient Access to Premium Medical Products, New Brands and Elevated Shopping ExperienceNEW YORK and TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN, OTCID: ITHUF), which owns, operates and partners with regulated cannabis operations across the United States, has announced its expansion into Fort Myers with the opening of its 24th GrowHealthy dispensary in Florida. The new location opens its doors today wit ...

LEWISVILLE, Ark., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Smackover Lithium, a 55:45 owned Joint Venture (“JV”) between Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI) and Equinor (“Equinor”), announced today that it has filed its Maiden Inferred Resource report (the “Report”) for the Franklin Project (the “Project”) in the northeast region of Texas. All terms not otherwise defined have the meaning given to them under the CIM Definition Standards for mineral resources and min ...

Taipei, Taiwan, Nov. 05, 2025 (GLOBE NEWSWIRE) -- YD Bio Limited (“YD Bio” or the “Company”) (NasdaqGM: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced its support for the global commercialization of OkaiDx™, a research‑use‑only (RUO) blood test for post‑treatment breast cancer monitoring now available through the Company’s affiliate EG Biomed US Inc. (“EG BioMed”)’s CLIA/CAP‑certified laboratory in the United States. ...

MONTRÉAL, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Falco Resources Ltd. (TSX-V:FPC) (“Falco” or the “Corporation”) is pleased to announce that it will begin a major exploration initiative across its significant holdings within the world-class Noranda Mining Camp (the “Noranda Camp”), which is located in the region of Abitibi, Québec, starting with an Airborne Gravity Gradiometry (“AGG”) survey (the “Survey”) over the next month. The Survey, a first for the region, will be utilized to identify new near surface Volc ...

TORONTO, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Research Ethics Board (“REB”) has granted approval for the Royal Columbian Hospital (RCH) to participate in Arch’s ongoing Phase II trial evaluating LSALT peptide for the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). With this ethics approval in place, the clinical team at RCH in New Westminster, British ...

Core Insights - Danbury Public Schools has integrated zSpace's AR/VR learning platform across its district, enhancing STEM education and career exploration for over 12,000 students [1][2][8] - The implementation includes the award-winning Career Coach AI, which provides localized career information and exploration opportunities [3][4] zSpace Technology Implementation - zSpace technology is deployed in Danbury High School West and three middle schools, focusing on hands-on STEM experiences and intelligent career guidance [1][2][4] - The Career Coach AI offers geo-located insights into career paths, utilizing data from authoritative sources like the Department of Labor [3][4] Educational Transformation - The integration of immersive AR/VR technology is aimed at preparing students for future careers, making complex concepts more accessible and engaging [4][5] - Students can explore various careers through virtual dissections, mechanical simulations, and 3D modeling, all within their classroom environment [5][6] Commitment to Career Readiness - Danbury Public Schools has introduced a district-wide 9th grade Career Exploration course, featuring customized zSpace activities aligned with the curriculum [6] - This foundational experience helps students understand diverse career paths and develop long-term educational visions [6] Company Overview - zSpace, Inc. is a leader in AR/VR educational solutions, trusted by over 3,500 educational institutions [9] - The company holds over 70 patents and focuses on enhancing learning through immersive experiences that improve student outcomes [9]

Save up to 60% on your holiday shopping with sales on wine, turkey and more at Grocery OutletEMERYVILLE, Calif., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet" or the "Company") is kicking off the holiday season with a number of special savings designed to help customers celebrate without breaking the bank. In addition to the company’s great everyday Xtreme Value™ Pricing on food and home items, Grocery Outlet has lined up even more Xtreme Value™ Deals and Prom ...

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Tradewinds Universal, Inc. (OTC: TRWD), a publicly traded holding company expanding within the entertainment sector, announced today the launch of a global media campaign designed to increase shareholder value, brand visibility and public recognition across North America, Latin America, and select international markets. The campaign, produced in collaboration with BizTrendWatch, a next-generation media and corporate communications platform known for spotlighting e ...

ATHENS, Greece, Nov. 05, 2025 (GLOBE NEWSWIRE) -- EuroHoldings Ltd. (NASDAQ: EHLD) (“EuroHoldings” or the “Company”) an owner and operator of ocean-going vessels and provider of seaborne transportation, announced today that it has signed a Memorandum of Agreement (MoA) to acquire, a medium-range (MR) product tanker vessel with capacity of 49,997 dwt, built in 2015 in South Korea, from an affiliated party. The vessel will be purchased for a price of $31.83 million, with delivery expected in mid-November 2025 ...

Jupiter, Florida, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ:JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based therapeutic platform targeting neuroinflammation and mitochondrial dysfunction, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application to initiate a Phase 2a clinical trial of JOTROL™ in patients with Parkinson’s disease. The FDA’s clearance marks a significa ...